Skip to main content
Advertisement
Advertisement

ELV

ELV logo

Elevance Health, Inc.

386.43
USD
Sponsored
+4.76
+1.25%
Oct 02, 15:59 UTC -4
Closed
exchange

Pre-Market

384.38

-2.05
-0.53%

ELV Earnings Reports

Positive Surprise Ratio

ELV beat 32 of 42 last estimates.

76%

Next Report

Date of Next Report
Oct 21, 2026
Estimate for Q3 26 (Revenue/ EPS)
$49.67B
/
$4.70
Implied change from Q2 26 (Revenue/ EPS)
-0.31%
/
-36.91%
Implied change from Q3 25 (Revenue/ EPS)
-0.83%
/
-22.06%

Elevance Health, Inc. earnings per share and revenue

On Jul 15, 2026, ELV reported earnings of 7.45 USD per share (EPS) for Q2 26, beating the estimate of 6.26 USD, resulting in a 18.85% surprise. Revenue reached 49.83 billion, compared to an expected 49.19 billion, with a 1.30% difference. The market reacted with a -8.54% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 19 analysts forecast an EPS of 4.70 USD, with revenue projected to reach 49.67 billion USD, implying an decrease of -36.91% EPS, and decrease of -0.31% in Revenue from the last quarter.
FAQ
For Q2 2026, Elevance Health, Inc. reported EPS of $7.45, beating estimates by 18.85%, and revenue of $49.83B, 1.3% above expectations.
The stock price moved down -8.54%, changed from $426.79 before the earnings release to $390.33 the day after.
The next earning report is scheduled for Oct 21, 2026.
Based on 19 analysts, Elevance Health, Inc. is expected to report EPS of $4.70 and revenue of $49.67B for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement